CLEVELAND, OHIO — Ganeden has made advancements for the usage of its GanedenBC30 shelf-stable probiotic strain in Canada thanks to recent regulatory changes. The company received a no objection letter from Health Canada, which provides further support for approved probiotic wording and allows Canadian manufacturers using the strain to make additional health claims.
 |
| David Keller, Ph.D., vice-president of scientific operations for Ganeden |
“Canada has become a strong market for probiotic fortification in foods and beverages, and we are dedicated to advancing regulatory approvals and probiotic language both there and internationally,” said David Keller, Ph.D., vice-president, scientific operations, Ganeden. “Our goal as a leader in the space is to make it as easy as possible for food and beverage manufacturers to fortify with a high-quality probiotic ingredient and to also provide direction on probiotic-related health claims and educational content.”
Ganeden also announced plans to continue its expansion and partnerships in the Canadian market, with multiple new probiotic products currently in development and expected to be completed within the next year. The company will be exhibiting at Canadian Health Food Association East in Toronto to showcase its line of probiotic offerings.
